Gedik, G. K.Yilmaz, F.Sari, O.2020-03-262020-03-2620172253-654Xhttps://dx.doi.org/10.1016/j.remn.2016.09.006https://hdl.handle.net/20.500.12395/35432Objective: The objective of this study was to investigate the relationship between level of F-18-fluorodeoxyglucose (F-18-FDG) accumulation in primary breast tumour assessed by positron emission tomography/computed tomography (PET/CT) and histopathological and clinical prognostic factors. Material and methods: A retrospective analysis was performed using the medical records of 58 female patients (age range: 31-86 years, mean age: 56) with biopsy of proven breast carcinoma, and who had undergone 18F-FDG PET/CT examination before chemotherapy/surgery. The 18F-FDG uptake of breast tumours was calculated as tumour to background ratio (TBR); which was compared with histopathological and clinical prognostic parameters. Results: The histology of the breast tumour in the 58 patients was ductal type in 52 (90%), lobular in 4 (7%), and mucinous in 2 (3%). Tumour size was <= 2 cm in 31 (53%) patients, and > 2 cm in 27 (47%). The levels of TBRs were not significantly different between the patients groups with tumours of 2 cm or less and greater than 2 cm (P= 0.131). No significant difference between levels of TBR was observed neither with regards to axillary lymph node involvement (P= 0.065) nor in terms of distant metastases (p = 0.123). No statistically significant difference was found in levels of TBRs between patients with c-erbB-2 receptor positive and negative ones (P= 0.107). Progesterone receptor (PR) expression was observed in 33 patients (57%), and 25 patients (43%) were PR negative. As regards progesterone receptor status, a statistically significant difference was observed in mean TBR levels between patients with and without progesterone receptor expression (P=0.020). Oestrogen receptor expression was positive in 41 (71%) patients, and negative in 17 (29%) patients. The difference in the levels of TBRs between patients with and without oestrogen receptor expression was at the level of significancy (P= 0.050). Conclusions: It is concluded that F-18-FDG uptake correlates with progesterone negativity of the tumour. However, a significant association with clinical prognostic parameters and level of 18F-FDG uptake levels could not be demonstrated. (C) 2016 Elsevier Espana, S.L.U. y SEMNIM. All rights reserved.en10.1016/j.remn.2016.09.006info:eu-repo/semantics/closedAccessBreast carcinomaPrognosisTumour to background ratioF-18-FDGArticle36315215727856207Q3WOS:000400803400004Q4